Antonin Rollet de Fougerolles

Antonin Rollet de Fougerolles

Chief Executive Officer at Evox Therapeutics Ltd.

59 year
Health Technology
Consumer Services

Profile

Currently, Antonin Rollet de Fougerolles occupies the position of Chief Executive Officer & Director at Evox Therapeutics Ltd.
He is also on the board of eTheRNA immunotherapies NV, Chimeron Bio Corp.
and Walking Fish Therapeutics, Inc. In his past career he was Chief Scientific Officer of Tolerx, Inc., VP-Research, Immunology, Metabolic & Viral Disease at Alnylam Pharmaceuticals, Inc., Chief Scientific Officer for Ablynx NV and Chief Scientific Officer of ModernaTX, Inc. Dr. De Fougerolles received a doctorate from Harvard University.

Antonin Rollet de Fougerolles active positions

CompaniesPositionStart
Chief Executive Officer -
Director/Board Member -
Director/Board Member -
Director/Board Member 2023-01-08
All active positions of Antonin Rollet de Fougerolles

Former positions of Antonin Rollet de Fougerolles

CompaniesPositionEnd
ABLYNX Chief Tech/Sci/R&D Officer 2018-01-31
Chief Tech/Sci/R&D Officer 2011-12-18
ALNYLAM PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2009-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Antonin Rollet de Fougerolles's experience

Training of Antonin Rollet de Fougerolles

Harvard University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Antonin Rollet de Fougerolles's experience

Connections

99

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ALNYLAM PHARMACEUTICALS, INC.

Health Technology

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Antonin Rollet de Fougerolles